![]()
- Late Payments on Credit Cards Drop in Third Quarter
- Kraft Weighs Higher Cadbury Bid as Rivals Circle
- MBS Program Should be Extended: Fed's Bullard
- Wall Street Finds Profits by Reducing Mortgages
- Microsoft, News Corp Weigh Online News Pact
- Warren Buffett, Bill Gates 'Walk & Talk' At Columbia
- Senate Democrats at Odds Over Health Care Bill
- Thanksgiving Week Stuffed With Economic News
- 10 Tips to Get Out of Debt
- CNBC VIDEO: Warren Buffett & Bill Gates 'Walk & Talk' at Columbia University
- U.S. Stocks Slip, Dollar Rises
- How Stock Investors Can Play Holiday Travel
- Time Lapse World Series Is A Great Play
- Hirschhorn: Greed...or Fear
- My Top 10 Tech Toys for the Holidays
- iPhone a Better Gaming Platform Than Android?
- May Day For Dendreon
- 100% Mortgage Financing From USDA
Stock futures pointed to a modest rebound ahead of the open Monday after the Dow and the S&P 500 experienced their biggest one-day percentage drops Friday since July 2.
Ford [F
Loading...
()
] was among the early market gainers after the automaker stunned Wall Street by reporting a quarterly profit and saying that 2011 should be "solidly profitable." Analysts had expected Ford to post a loss of 11 cents a share, but the company instead earned seven cents.
Ford shares rose 5.7 percent in premarket activity, most recently trading at $7.40 a share.
The market's other big mover was Human Genome Sciences [HGSI
Loading...
()
], which soared as much as 40 percent after the company said its experimental lupus drug was successful in a second clinical trial. It would be the first new lupus treatment in 50 years.
Also in the sector, Vertex Pharma [VRTX
Loading...
()
] shares leaped more than 10 percent after the company said a phase II study showed that twice-daily treatments of its experimental hepatitis C drug telaprevir worked as well as three times a day.
Elsewhere, Royal Caribbean [RCL
Loading...
()
] shares gained 3 percent premarket on an upgrade from Wells Fargo, and Progressive [PGR
Loading...
()
] shares jumped 8.8 percent after Barron's said the insurer was set to expand earnings and revenue for the first time in years.
Friday's market drop erased October gains for the S&P 500 and the Nasdaq and left the Dow up less than half a point for the month. Investors may experience a case of pre-Fed meeting jitters this week, but also have a number of key economic stats and earnings to get through as well.
There also could be watching market reaction to the bankruptcy filing by CIT Group, [CIT
Loading...
()
] which occurred over the weekend following the failure of a proposed debt exchange offer to bondholders. The filing is one of the biggest in U.S. corporate history. CIT shares tumbled 47 percent premarket.
Among the other earnings reports out this morning: Clorox [CLX
Loading...
()
]; Dean Foods [DF
Loading...
()
]; Humana [HUM
Loading...
()
]; Loews [L
Loading...
()
]; and Sysco [SYY
Loading...
()
].
On the economic calendar, the Institute for Supply Management is out with its monthly manufacturing index at 10 am. Economists are looking for a reading of 53.0, above the 50 mark that represents the dividing line between contraction and expansion. The ISM index came at 52.6 last month. Note that auto sales for October will be out Tuesday.
Wal-Mart [WMT
Loading...
()
] has announced a second round of toy price cuts for the holiday season, which could spark an accelerated price war between retailers.
In M&A news this morning, Denbury Resources [DNR
Loading...
()
] has agreed to buy Encore Acquisition [EAC
Loading...
()
] for $3.2 billion in cash and stock, creating one of North America's largest oil production and exploration companies. The deal represents a 35 percent premium for Encore shareholders.
- Written by Peter Schacknow, Senior Producer, CNBC Breaking News Desk
- Technology can make or break a fortune in the world of alternative energy.
- Warren Buffett and Bill Gates discuss the economy and other subjects with CNBC's Becky Quick.
- Many people are facing the holidays with substantially smaller incomes. Here’s how some are adapting.
- Jim Cramer is a proponent of stocks that pay healthy dividends, and here are his top five dividend plays.
- The homebuyer's tax credit jacked sales for a while, but 2010 is looking weak. Now what?
- CNBC’s technology reporter Jim Goldman guides you through the best gadgets to buy this holiday season.












